Browsing Category

Features

1035 posts

Novel Excipients: Gaining Traction in the Industry
By

By
The FDA is considering a pilot program for the toxicological and quality evaluation of novel excipients. Excipients now are not separately reviewed by the FDA, and some say a separate…

President Signs Executive Orders on Drug Pricing
By

By
Reforming drug pricing in the US has emerged again with the signing of executive orders by President Trump late last week. What do the executive orders require, and what is…

What’s Trending in Biomanufacturing?
By

By
A recent analysis by BioPlan Associates outlines the major trends impacting biomanufacturing and related supply lines. From the impact of the COVID-19 pandemic to ways to increase biomanufacturing productivity to…

2020 Vision: China and Pharma
By

By
China is the second largest national pharmaceutical market in the global pharma industry and a large supplier of pharma ingredients globally. In the wake of COVID-19 and related economic and…

The EU’s Recovery Plan: What It Means for Pharma
By

By
Leaders from the European Union (EU) have reached an historic agreement in breadth and size to create a EUR 750 billion ($864 billion) recovery fund to rebuild EU economies in…

EU’s Pharma Strategy: Secure the Supply Chain & Innovation
By

By
The industry is weighing in on the European Commission’s proposed Pharmaceutical Strategy for Europe, which sets forth a roadmap for innovation, manufacturing, and medicines supply in Europe, including the COVID-19…

Pandemic Complicates an Already Challenging Outlook for the Global Pharma Industry 
By

By
The COVID-19 pandemic has greatly complicated an already challenging outlook for the global pharmaceutical industry. Graham Lewis, Vice President, Global Pharma Strategy, IQVIA lays out sales, cost, and supply impacts…

Re-configuring Global Pharma Supply Chains
By

By
In the wake of the COVID-19 pandemic and concerns over pharmaceutical supply-chain vulnerabilities, the policy debate to repatriate and increase domestic drug manufacturing in the US is receiving increased attention.…

Market Watch: Dosage-Form Development and Manufacturing
By

By
Formulation and drug-delivery technologies play an important role in new product development, both in formulations with new active pharmaceutical ingredients (APIs) and in new routes of administration for existing APIs.…

2020 Vision: Digital Pharma—Beyond the Pill
By

By
Digitalization is playing an increasingly important role in drug-development and commercialization, but how about in new products themselves? Are digital medicines the wave of the future or an interesting, but…